Grindlays Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 20-12-2024
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.86 Cr
as on 20-12-2024
- Satisfied Charges ₹ 9.60 Cr
as on 20-12-2024
- Revenue 104.13%
(FY 2022)
- Profit 165.52%
(FY 2022)
- Ebitda 69.53%
(FY 2022)
- Net Worth 49.54%
(FY 2022)
- Total Assets 39.34%
(FY 2022)
About Grindlays Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.86 Cr. The company has closed loans amounting to ₹9.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Santosh Kolwankar, Ramkrishna Kolwankar, Dhanashri Gudi, and One other member serve as directors at the Company.
- CIN/LLPIN
U99999MH1985PTC037368
- Company No.
037368
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Grindlays Pharmaceuticals Pvt Ltd offer?
Grindlays Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Feed Additives, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material, Industrial Chemicals & Supplies, Aldehydes, Cardiovascular Drugs & Medication, Diabetes Medicine, API Intermediate, Etoricoxib Intermediate.
Who are the key members and board of directors at Grindlays Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramkrishna Kolwankar  | Managing Director | 15-Oct-1985 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhanashri Gudi | Director | 31-Mar-1995 | Current |
| Santosh Kolwankar | Director | 16-Nov-2009 | Current |
| Arti Kolwankar | Director | 01-Apr-1997 | Current |
Financial Performance of Grindlays Pharmaceuticals.
Grindlays Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 104.13% increase. The company also saw a substantial improvement in profitability, with a 165.52% increase in profit. The company's net worth Soared by an impressive increase of 49.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grindlays Pharmaceuticals?
In 2022, Grindlays Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 27 Sep 2008 | ₹5.86 Cr | Open |
Deutsche Bank Ag Creation Date: 31 Jul 2013 | ₹3.55 Cr | Satisfied |
Bank Of India Creation Date: 18 Mar 2009 | ₹1.20 M | Satisfied |
How Many Employees Work at Grindlays Pharmaceuticals?
Grindlays Pharmaceuticals has a workforce of 12 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grindlays Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grindlays Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
